Back to Results
First PageMeta Content
Medicine / Research / European Union / Pharmacology / Biotechnology / European Medicines Agency / Clinical Trials Directive / Directive 2001/83/EC / Cell therapy / Clinical research / Biology / Pharmaceuticals policy


HUMAN TISSUE ENGINEERING AND BEYOND: PROPOSAL FOR A COMMUNITY REGULATORY FRAMEWORK ON ADVANCED THERAPIES 04 May 2005
Add to Reading List

Document Date: 2013-10-09 09:46:40

Open Document

File Size: 63,47 KB

Share Result on Facebook

City

Brussels / /

Company

Advanced Therapies / /

Country

Belgium / /

/

/

IndustryTerm

gene therapy medicinal product / final product / cellular products / therapy medicinal products / biotechnology / somatic cell therapy medicinal product / medical devices / pharmaceutical sector / non-xenogeneic somatic cell therapy medicinal products / scientific advisory groups / medicinal product / non-industrial manufacturing process / chemical substances / risk management / manufacturing practice / therapy medicinal product / medicinal products / biotechnology sector / concerned medicinal product / manufacturing process / /

MedicalTreatment

gene therapy / cell therapy / /

Organization

COUNCIL on Advanced Therapies / Product Characteristics / Labelling and Package Leaflet CHAPTER / Committee for Advanced Therapies / European Medicines Agency / EN CHAPTER / European Commission / Committee for Medicinal Products for Human Use / EUROPEAN PARLIAMENT / COUNCIL OF THE EUROPEAN UNION / Marketing Authorisation Requirements CHAPTER / Committee of the Regions3 / Committee for Orphan Medicinal Products / /

Person

Nicolas Rossignol / /

Position

Chairman / Executive Director / /

ProgrammingLanguage

EC / /

Technology

gene therapy / cell therapy / TISSUE ENGINEERING / biotechnology / /

URL

http /

SocialTag